Which liquid biopsy analytes have the highest potential for improved patient stratification in clinical trials within the next 5 years?

Vote below
165 votes
Cell-free DNA
43%
111 votes
Circulating tumor cells
29%
48 votes
Exosomes / extracellular vesicles
13%
27 votes
Cell-free RNA / miRNA
7%
30 votes
Multiple analytes
8%